This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Chl Industries, LLC. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: John P. McCook: Innovator in Actinic Keratosis Treatment
Introduction
John P. McCook is a notable inventor based in Austin, TX, who has made significant contributions to the field of dermatological treatments. He holds a patent that focuses on innovative methods for treating and preventing actinic keratosis, a common skin condition caused by sun exposure. His work aims to improve the quality of life for individuals affected by this condition.
Latest Patents
John P. McCook's most recent patent is titled "Compositions and methods for treatment and prevention of actinic keratosis using copper chlorin." This patent describes treatment compositions and methods for treating and/or preventing actinic keratosis by applying a chlorin treatment composition in a topical form to one or more actinic keratosis lesions. The treatment composition preferably includes a copper chlorin, such as a sodium copper chlorophyllin complex, trisodium copper chlorin p6, disodium copper isochlorin e4, or trisodium copper chlorin e6. The formulation comprises around 0.002% to around 0.1% by weight of copper chlorin. The treatments disclosed may result in the elimination of actinic keratosis lesions.
Career Highlights
John P. McCook is associated with Chl Industries, LLC, where he continues to develop innovative solutions in the field of dermatology. His dedication to research and development has led to advancements that benefit patients suffering from skin conditions.
Collaborations
John has collaborated with David Bruce Vasily, contributing to the development of effective treatment methods in their field.
Conclusion
John P. McCook's work in the treatment of actinic keratosis showcases his commitment to innovation in dermatological care. His patent reflects a significant advancement in the methods available for treating this skin condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile